Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Clasificación en acciones #41013
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Precio por acción
$0.00185055
Capitalización bursátil
$48.29K
Cambio (1 día)
-3.55%
Cambio (1 año)
30.31%
País
GB
Comercio Nuformix plc (NFX)

Categoría

Ganancias de Nuformix plc (NFX)
Ganancias en Mar 2026 TTM: $-857.89K
Secondo gli ultimi rapporti finanziari di Nuformix plc, gli utili attuali della società sono $-857.89K. Nel 2024, la società ha registrato un utile di $-4.88M, una disminución en comparación con agli utili del 2023, che erano di $-754.56K. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Nuformix plc desde 2014 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
2026 (TTM) $-857.89K -3.39%
2025 $-888.01K -81.80%
2024 $-4.88M 546.72%
2023 $-754.56K -54.82%
2022 $-1.67M -11.94%
2021 $-1.90M 64.37%
2020 $-1.15M -51.92%
2019 $-2.40M -12.87%
2018 $-2.75M 220.48%
2017 $-859.40K 70.68%
2016 $-503.51K -206.04%
2014 $474.83K 0.00%
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$5.27B -614,967.33%
US
$-3.09B 359,735.34%
US
$-4.02B 468,046.88%
AU
$1.95B -227,477.01%
NL
- -
CH